Circulation

Vol. 152, Issue Suppl_3 Issue Suppl_3 2025
4221
Articles

Articles in this Issue

Abstract 4335947: Resistance Training and Risk of Type 2 Diabetes and Cardiovascular Disease in Women: A Prospective Cohort Analysis from the Nurses' Health Study

Tianyue Zhang, Edward Giovannucci Nov 04, 2025 10.1161/circ.152.suppl_3.4335947

Background: Resistance training may help reduce the risk of chronic diseases, but evidence among women remains limited. Ob...

Abstract 4364886: The Association Between Tricuspid Regurgitation And Clinical Outcomes In Patients With Cardiac Amyloidosis

Niyoosha Yoosefi, Ding Yuan Wang, Mehima Kang et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4364886

Background: Cardiac amyloidosis (CA) is a progressive infiltrative cardiomyopathy associated with poor prognosis. CA is commonly due to transthyretin (ATTR) or light chain (AL) amy...

Abstract 4367597: Temporal Trends of Contributing Cardiovascular Mechanisms of Mortality in Patients with Atrial Fibrillation Stratified by Age and Sex

Ashley Goodwin, Jacqueline Dickey, Bobby Endo et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4367597

Background: Atrial Fibrillation (AF) is a significant cause of cardiovascular morbidity and mortality risk. Age is a powerful predictor of adverse outcomes in patients with AF. In...

Abstract 4339322: SGLT2 Inhibitors and Long-Term Outcomes in Kidney Transplant Recipients: A Propensity-Matched Cohort Study

Sadaf Esteghamati, Ibrahim Kamel, Ahmed Mahmoud et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4339322

Background: Cardiovascular disease is a leading cause of morbidity and mortality among kidney transplant recipients, driven by traditional risk factors and immunosuppressive therap...

Abstract 4360298: Examining associations of medical discrimination and the hypertension cascade among adults in the All of Us Research Program

Vincent Pepe, Yashika Sharma, Meghan Reading Turchioe et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4360298

Background: Hypertension (HTN) is the leading risk factor for cardiovascular disease. Medical discrimination (i.e., discrimination in healthcare settings) is linked to poor disease...

Abstract 4348120: Mortality Trends and Disparities In Hypothyroidism and Ischemic Heart Disease in the United States from 1999 to 2020: A CDC WONDER Analysis

Maryam Asghar, KINZA Asghar, Allahdad Khan et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4348120

Background: Patients with ischemic heart disease and hypothyroidism face a higher risk of death compared to euthyroid individuals in the U.S. The relationship between Hypothyroidis...

Abstract 4366824: Protection of PDCD4 against doxorubicin-induced cardiotoxicity

Fan Li, Wuqiang Zhu Nov 04, 2025 10.1161/circ.152.suppl_3.4366824

Background: Programmed Cell Death 4 (PDCD4) is a tumor suppressor known for promoting apoptosis and inhibiting growth and protein translation in cancer cells. However, the role of...

Abstract 4365480: Geographic, Gender, and Age Disparities in Aortic Aneurysm Burden: Insights from GBD 2021 U.S. Dat

Sameer Kumar Majety, Deepak Vedamurthy, Himaja Anne et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4365480

Background: Aortic aneurysm is a fatal but preventable cause of cardiovascular mortality. We used GBD 2021 U.S. data to analyze geographic, gender, and age disparities in death and...

Abstract 4339739: SGLT-2 Inhibitors in the Prevention of Chemotherapy-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis

Soomal Rafique, Mukul Bhattarai Nov 04, 2025 10.1161/circ.152.suppl_3.4339739

Background: Chemotherapy is linked to significant cardiotoxicity. While guideline-directed heart failure therapies help mitigate these effects, the role of sodium-glucose cotranspo...

Abstract 4359184: Trends in Mortality Due to Heart Failure and Gastrointestinal Hemorrhage in the United States: A Retrospective Analysis of CDC WONDER Database

Mahmood Danishwar, Huzaifa Noor, Tehreem Asghar et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4359184

Introduction: Weakening of cardiac function in Heart Failure is clinically associated with Gastrointestinal Hemorrhage. This study investigates mortality trends to identify dispari...

Abstract 4365822: Alleviating radiation-induced cardiovascular disease with a radioprotective fullerene derivative

Khadijeh Koushki, Sivareddy Kotla, Sunil Krishnan Nov 04, 2025 10.1161/circ.152.suppl_3.4365822

Despite modern radiation therapy (RT) advancements, radiation-induced cardiovascular (CV) disease remains a significant cause of morbidity and mortality among cancer patients. Reactive oxygen species...

Abstract Sat305: Race and Ethnicity Classification via Deep Learning Electrocardiogram Analysis

Luca Neri, Alessandro Orro, Ivan Corazza et al. Nov 04, 2025 10.1161/circ.152.suppl_3.sat305

Background: Cardiovascular diseases are a leading cause of morbidity and mortality worldwide. Demographics, including race/ethnicity, are among...

Abstract 4369836: Diagnostic Accuracy of AI Algorithms for Detecting Left Ventricular Diastolic Dysfunction on ECG: A Systematic Review and Meta-Analysis

JOHANN ALEXANDRE CHAFA EDJIMBI, Aryan Gajjar, Nisarg Shah et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4369836

Background: Left ventricular diastolic dysfunction (LVDD), a key precursor to heart failure with preserved ejection fraction, is frequently underdiagnosed using on routine electroc...

Abstract 4340497: Cardiopulmonary Resuscitation Coach Training with Modified Resuscitation Cart Improves Provider Knowledge and Perception of Pediatric Resuscitation Efficiency

Hunter Daigle, Ada Earp, Amanda Puro et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4340497

Background: High-quality cardiopulmonary resuscitation (CPR) is critical for survival after pediatric cardiac arrest, yet adherence to guideline metrics and timely utilization of e...

Abstract 4360925: A phenomapping-informed machine learning tool estimates individualized cardiometabolic effects from Tirzepatide and generalizes to a new population.

Phyllis Thangaraj, Evangelos Oikonomou, Rohan Khera Nov 04, 2025 10.1161/circ.152.suppl_3.4360925

Background: Tirzepatide induces weight loss (WL), but its precise use among those more likely to benefit from WL and experience cardiometabolic effects can enable more scalable dep...

Abstract 4372054: Pembrolizumab-Induced Myositis Unmasking Double M Syndrome with Smoldering Myocarditis

Ruben Tapia-Orihuela, Justin Mark, Alexander Llanos et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4372054

Background: Immune checkpoint inhibitors (ICIs), such as pembrolizumab, have revolutionized cancer therapy but can trigger immune-related adverse events (irAEs), including myocardi...

Abstract 4366192: Energy Insecurity Associates with Increased Odds of Cardiovascular Disease Risk Factors and Burden: Data from the Behavioral Risk Factor Surveillance System, 2023

Joniqua Ceasar, Lin Yang, Jingyi Wu et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4366192

Introduction: Over a quarter of US households experience energy insecurity (EI) - the inability to meet household energy needs - and this number is expected to rise due to increasi...

Abstract 4346602: Impact of Novel Genetic Variants of Thoracic Aortic Aneurysm and Dissection Derived from a Community Cohort Study in Yamagata, Japan, for Preventive Aortic Therapy

Kentaro Akabane, Ken Nakamura, Tetsuro Uchida Nov 04, 2025 10.1161/circ.152.suppl_3.4346602

Background: Thoracic aortic aneurysms and dissections (TAAD) are primarily associated with acquired factors. However, 20% of cases exhibit familial clustering, indicating a genetic...

Abstract 4367078: The Association between Non-High-Density Lipoprotein Cholesterol Level and Coronary Fatty Plaque Regression

Tarec Elajami, Ralph Daher, Abdulhamied Alfaddagh et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4367078

Background: Regression of coronary fatty plaque, the type most prone to rupture and cause acute coronary syndromes, is associated with fewer cardiovascular events. A baseline non-H...

Abstract 4368894: The efficacy of computerized cognitive training in patients with coronary heart disease and cognitive impairment, no dementia: a randomized controlled trial (COG-T CHD)

Qing Chen, Yi Ye, Xiaoping Liu et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4368894

Background: Adaptive digital therapy can improve the effect of cognitive training compared to traditional methods, but there is no related evidence in patients with coronary heart...

Abstract 4373218: Safety and Efficacy of Moderate-Intensity Statin Plus Ezetimibe versus High-Intensity Statin in Older Adult Patients: A Meta-analysis

Meghna Joseph, Mrinal Krishna, Chidubem Ezenna et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4373218

Introduction: Guidelines recommend high-intensity statin treatment for achieving target low-density lipoprotein cholesterol (LDL-C) levels in high-risk patients. Nonetheless, moder...

Abstract 4361559: Optimal Medical Therapy and Uncontrolled Risk Factors in Patients with Chronic Coronary Syndrome Undergoing PCI: Temporal Trends and Clinical Outcomes

Oludamilola Akinmolayemi, Angelo Oliva, Samantha Sartori et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4361559

Background: Despite guidelines recommending revascularization for refractory angina after optimal medical therapy (OMT) in chronic coronary syndrome patients (CCS), limited studies...

Abstract 4366819: Clinical outcomes in patients with early right ventricular failure during index admission after HeartMate 3 LVAD implantation

Flavia Tejada Frisancho, Zhi Li, Liza Shaban et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4366819

Background: Despite the survival benefit of durable left ventricular assist devices (LVAD) in patients with end stage heart failure, right ventricular failure (RVF) remains a promi...

Abstract 4370846: Real-World Outcomes of Inclisiran vs. Ezetimibe in Statin-Treated Coronary Artery Disease Patients: A 1-Year Observational Analysis

Usman Akbar, Hasnan ijaz, Heriberto Cantu et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4370846

Background: Residual risk of adverse cardiovascular events remains high among patients with coronary artery disease (CAD) despite high-intensity statin therapy. Although ezetimibe...

Abstract 4368934: Bachmann’s bundle-related atrial tachycardias following catheter ablation of persistent atrial fibrillation

Nathaniel Christian-Miller, Mohammed Al-Sadawi, Muazzum Shah et al. Nov 04, 2025 10.1161/circ.152.suppl_3.4368934

Background: Atrial tachycardias (AT) after radiofrequency ablation (RFA) of atrial fibrillation (AF) may utilize Bachmann’s bundle (BB). Due to their epicardial location, these ATs...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page